Oryzon Genomics S.A. (ORYZF) - Financials, balance sheet (quarterly)

3.030000 USD

Last update May 21, 9:30 AM EDT

Market closed

Day range

3.030000

Previous close

3.030000

Open

3.030000

Access this stock data via API

Oryzon Genomics S.A.

3.03

Financials

Balance sheet

Fiscal date	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total assets	122.7M	110.7M	96.0M	106.9M
Current assets	—	13.9M	9.5M	14.3M
Cash	—	10.1M	—	12.3M
Cash equivalents	—	—	—	—
Cash and cash equivalents	8.4M	10.1M	9.5M	12.3M
Other short term investments	—	—	—	—
Accounts receivable	—	1.1M	—	1.4M
Other receivables	—	1.0M	—	647.0K
Inventory	—	7.1K	—	6.0K
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	—	96.8M	86.4M	92.6M
Properties	—	1.1M	—	1.1M
Land and improvements	—	—	—	—
Machinery furniture equipment	—	1.6M	—	1.6M
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	-2.3M	—	-2.2M
Goodwill	—	94.0M	—	89.9M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	94.0M	—	89.9M
Investments and advances	—	—	—	—
Other non current assets	—	—	—	—
Total liabilities	25.8M	24.2M	22.2M	25.1M
Current liabilities	—	14.6M	0	16.4M
Accounts payable	—	2.4M	—	3.4M
Accrued expenses	—	—	—	—
Short term debt	—	10.2M	—	10.2M
Deferred revenue	—	—	—	—
Tax payable	—	200.7K	—	204.2K
Pensions	—	86.9K	—	86.9K
Other current liabilities	—	—	—	—
Non current liabilities	—	9.5M	22.2M	8.7M
Long term provisions	—	330.1K	—	154.8K
Long term debt	—	3.2M	—	3.5M
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	2.4M	—	2.2M
Derivative product liabilities	—	—	—	2.9M
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	—	3.2M	—	3.1M
Retained earnings	—	-16.7M	—	-15.7M
Other shareholders equity	—	—	—	—
Total shareholders equity	96.9M	86.5M	73.8M	81.8M
Additional paid in capital	—	97.7M	—	92.4M
Treasury stock	—	2.1M	—	546.6K
Minority interest	—	—	—	—